Cataract Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Cataract is a clouding of the normally clear lens of eye that affects vision. Symptoms include clouded, blurred or dim vision, increasing difficulty with vision at night, fading or yellowing of colors, double vision in a single eye and frequent prescription changes in eye wear.
The cataract pipeline drugs market research report provides an analysis of the cataract drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases covering the product development milestones. Additionally, the report provides an overview of key players involved in therapeutic development for cataract and features dormant and discontinued projects.
Cataract Pipeline Drugs Market Segmentation by Targets
Some of the targets of the cataract pipeline drugs market are Alpha Crystallin A Chain, Alpha Crystallin B Chain, Calpain 1 Catalytic Subunit, Calpain 2 Catalytic Subunit, and Nuclear Factor Kappa B.
Cataract Pipeline Drugs Market Analysis, by Key Targets
For more insights on key targets, download a free report sample
Cataract Pipeline Drugs Market Segmentation by Mechanisms of Action
The key mechanisms of action of the cataract pipeline drugs market are Alpha Crystallin A Chain Activator, Alpha Crystallin A Chain Inhibitor, Alpha Crystallin B Chain Inhibitor, Calpain 1 Catalytic Subunit Inhibitor, Calpain 2 Catalytic Subunit Inhibitor and Nuclear Factor Kappa B Inhibitor.
Cataract Pipeline Drugs Market Analysis, by Key Mechanisms of Action
For more insights on key mechanisms of action, download a free report sample
Cataract Pipeline Drugs Market Segmentation by Routes of Administration
The routes of administration in the cataract pipeline drugs market are ophthalmic, topical, intravenous and parenteral.
Cataract Pipeline Drugs Market Analysis, by Routes of Administration
For more insights on routes of administration, download a free report sample
Cataract Pipeline Drugs Market Segmentation by Molecule Types
The molecule types in the cataract pipeline drugs market are small molecule, monoclonal antibody conjugated and synthetic peptide.
Cataract Pipeline Drugs Market Analysis, by Molecule Types
For more insights on molecule type, download a free report sample
Competitive Landscape
Some of the key companies in the cataract pipeline drugs market are Plex Pharmaceuticals Inc, Calpain Therapeutics Pty Ltd, Caregen Co Ltd, Cellix Bio Pvt Ltd, CGeneTech (Suzhou China) Co Ltd, Genisphere LLC, Kubota Vision Inc, Nacuity Pharmaceuticals Inc, Optus Pharmaceutical Co Ltd, Plex Pharmaceuticals Inc, Reven Holdings Inc, ViewPoint Therapeutics Inc and Vitreo Pharma Inc.
Cataract Pipeline Drugs Market Analysis, by Leading Companies
For more insights on leading companies, download a free report sample
Cataract Pipeline Drugs Market Report Overview
Key Targets | Alpha Crystallin A Chain, Alpha Crystallin B Chain, Calpain 1 Catalytic Subunit, Calpain 2 Catalytic Subunit, and Nuclear Factor Kappa B |
Key Mechanisms of Action | Alpha Crystallin A Chain Activator, Alpha Crystallin A Chain Inhibitor, Alpha Crystallin B Chain Inhibitor, Calpain 1 Catalytic Subunit Inhibitor, Calpain 2 Catalytic Subunit Inhibitor and Nuclear Factor Kappa B Inhibitor |
Key Routes of Administration | Ophthalmic, Topical, Intravenous and Parenteral |
Key Molecule Types | Small Molecule, Monoclonal Antibody Conjugated and Synthetic Peptide |
Leading Companies | Plex Pharmaceuticals Inc, Calpain Therapeutics Pty Ltd, Caregen Co Ltd, Cellix Bio Pvt Ltd, CGeneTech (Suzhou China) Co Ltd, Genisphere LLC, Kubota Vision Inc, Nacuity Pharmaceuticals Inc, Optus Pharmaceutical Co Ltd, Plex Pharmaceuticals Inc, Reven Holdings Inc, ViewPoint Therapeutics Inc and Vitreo Pharma Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Cataract (Oncology).
- The pipeline guide reviews pipeline therapeutics for Cataract (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Cataract (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Cataract (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Cataract (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Cataract (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Cataract (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Caregen Co Ltd
Cellix Bio Pvt Ltd
CGeneTech (Suzhou China) Co Ltd
Genisphere LLC
Kubota Vision Inc
Nacuity Pharmaceuticals Inc
Optus Pharmaceutical Co Ltd
Plex Pharmaceuticals Inc
Reven Holdings Inc
ViewPoint Therapeutics Inc
Vitreo Pharma Inc
Table of Contents
Frequently asked questions
-
What are the targets of the cataract pipeline drugs market?
Some of the targets of the cataract pipeline drugs market are Alpha Crystallin A Chain, Alpha Crystallin B Chain, Calpain 1 Catalytic Subunit, Calpain 2 Catalytic Subunit, and Nuclear Factor Kappa B.
-
What are the mechanisms of action of the cataract pipeline drugs market?
The key mechanism of action of the cataract pipeline drugs market are Alpha Crystallin A Chain Activator, Alpha Crystallin A Chain Inhibitor, Alpha Crystallin B Chain Inhibitor, Calpain 1 Catalytic Subunit Inhibitor, Calpain 2 Catalytic Subunit Inhibitor and Nuclear Factor Kappa B Inhibitor.
-
What are the routes of administration in the cataract pipeline drugs market?
The routes of administration in the cataract pipeline drugs market are Ophthalmic, Topical, Intravenous and Parenteral.
-
What are the molecule types in the cataract pipeline drugs market?
The molecule types in the cataract pipeline drugs market small molecule, monoclonal antibody conjugated and synthetic peptide.
-
Which are the leading companies in the cataract pipeline drugs market?
Some of the leading companies in the cataract pipeline drugs market are Plex Pharmaceuticals Inc, Calpain Therapeutics Pty Ltd, Caregen Co Ltd, Cellix Bio Pvt Ltd, CGeneTech (Suzhou China) Co Ltd, Genisphere LLC, Kubota Vision Inc, Nacuity Pharmaceuticals Inc, Optus Pharmaceutical Co Ltd, Plex Pharmaceuticals Inc, Reven Holdings Inc, ViewPoint Therapeutics Inc and Vitreo Pharma Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Ophthalmology reports

